.jpg/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=h:100){kind=logo}
The Numbers
70 Million
3.4 Million
3.4 Million
People with Epilepsy Worldwide
3.4 Million
3.4 Million
3.4 Million
People with Epilepsy in the USA
150,000
3.4 Million
150,000
New Cases Annually in the USA
The PROBLEM
"Endless" Titration Loop
Physicians rely on self reported seizure data to manage their patient's epilepsy - particularly in determining the right medication and the right dose. However, studies have shown that this data is up to 50% in accurate.
Increased Costs while outcomes stagnant
A recent study showed that in the USA, direct costs related to Epilepsy have almost doubled in the last decade to $28B per year, while outcomes have not improved in almost three decades.
The Potential Benefits
Improving Outcomes
Improving Quality of Life
Improving Quality of Life
By helping physicians get the data they need to make timely medical decisions.
Improving Quality of Life
Improving Quality of Life
Improving Quality of Life
Getting patients on path to seizure freedom quicker and reducing the burden of tracking seizures.
Reducing Costs
Improving Quality of Life
Reducing Costs
Helping providers and patients reduce the number of costly visits to the hospital.
The Evidence
Preliminary
We recently completed a 30 patient proof-of-concept study which resulted in robust seizure detection of the subtlest seizure type, absence seizures.
Upcoming
We are currently preparing for a more in depth clinical study involving several clinical collaborators.
Our Team
Rachel Kuperman, MD, Founder & CEO
Rachel Kuperman, MD, Founder & CEO
Rachel Kuperman, MD, Founder & CEO
Neurologist with dual certification in epilepsy and neurology with over 10 years’ experience directing the clinical epilepsy and research programs at UCSF Benioff Children’s Hospital, Oakland
Jit Sarkar, Co-Founder and CTO
Rachel Kuperman, MD, Founder & CEO
Rachel Kuperman, MD, Founder & CEO
Leads the algorithm development for Eysz solution. He completed his undergraduate degree in computer science and has deep experience applying machine learning methods. His PhD from UCSD focused on extracting signals from a complex medium.
Parth Amin, Co-Founder and Chief Commercial Officer
Parth Amin, Co-Founder and Chief Commercial Officer
Parth Amin, Co-Founder and Chief Commercial Officer
Experienced clinical device development and go-to-market strategist with 15+ years of global medical device and partnership experience. Currently develops and manages our partner ecosystem.
Nicolle Napier - Ionascu Chief Neuropsychologist
Parth Amin, Co-Founder and Chief Commercial Officer
Parth Amin, Co-Founder and Chief Commercial Officer
Leads the Eysz cognitive research team. Practicing neuropsychology for over 12 years primarily in the Bay Area. She is also the head Neuropsychologist in the Epilepsy department at UCSF Benioff Children’s Hospital Oakland
Our Advisors
Robert Fisher, MD Scientific Advisor
Robert Fisher, MD Scientific Advisor
Robert Fisher, MD Scientific Advisor
Dr. Fisher is Maslah Saul MD Professor and Director of the Stanford Epilepsy Center. He had research awards from the Klingenstein Foundation, EF, CURE and NIH. He published 160 peer-reviewed articles and 4 books. He was named 1996-2016 in Best Doctors in America. He received the Ambassador Award from the International League Against Epilepsy, the 2005 AES Service Award and the 2006 Annual Clinical Research Award.
Hal Blumenfeld, MD Scientific Advisor
Robert Fisher, MD Scientific Advisor
Robert Fisher, MD Scientific Advisor
Dr. Blumenfeld's clinical and research work focuses on epilepsy, cognition and brain imaging. He directs Yale's Clinical Neuroscience Imaging Center (CNIC), a new multi-disciplinary core facility for innovative study and treatment of brain disorders. Teaching activities include a textbook titled Neuroanatomy Through Clinical Cases, Sinauer Assoc., Publ. 2002, 2010.
Peter Milford, PhD Technical Advisor
Peter Milford, PhD Technical Advisor
Peter Milford, PhD Technical Advisor
Dr. Milford has over 15 years experience in developing high technology instrumentation. He was CTO of Eyefluence, which was developing the next generation eye-tracking wearable technology, up until October 2016, when purchased by Google. He continued to develop eye interaction and eye tracking for augmented reality (AR) and virtual reality (VR) headsets. He now serves as the President of Parallel Rules consulting firm.
Steve Duddy Business Advisor
Peter Milford, PhD Technical Advisor
Peter Milford, PhD Technical Advisor
Steve brings 30+ years of leadership and strategy experience in the Medical Device industry. He has held a variety of leadership roles in various cross functional areas. Most recently, he is serving as the President and Chairman of Nuvolase Inc., which has developed the gold standard for Onychomycosis. Under his leadership, the company has grown in revenues, remained debt-free, and has expanded into new markets.
Board of Directors
Randy Berholtz JD, MBA
Randy leverages his corporate experience, where he has held roles as a corporate and business development executive and as general counsel, to help nurture over 25 startups in healthcare from funding, to serving as a board of director to corporate and business development and strategic initiatives. He currently services as a Partner for Ventac Partners and a Senior Advisor for Mesa Partners. He is also a parent of a child with epilepsy.